Rutin-loaded film-forming spray for accelerated wound repair: a QbD-guided translational approach.

IF 2.9 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Preeti Karwa, Ayesha Syed, Sohal Mallick, Mohd Osama Nabi
{"title":"Rutin-loaded film-forming spray for accelerated wound repair: a QbD-guided translational approach.","authors":"Preeti Karwa, Ayesha Syed, Sohal Mallick, Mohd Osama Nabi","doi":"10.1080/10837450.2026.2682783","DOIUrl":null,"url":null,"abstract":"<p><p>Wound healing remains a major clinical challenge, necessitating advanced topical systems that accelerate repair while minimizing complications. Rutin, a flavonoid with potent antioxidant, anti-inflammatory and angiogenic properties, suffers from poor solubility and instability, limiting therapeutic application. To overcome these drawbacks, a rutin-loaded film-forming spray (FFS) was developed using a Quality by Design (QbD) framework and optimized <i>via</i> a Box-Behnken design. Eudragit<sup>®</sup> RLPO and Eudragit<sup>®</sup> E100 were employed as film-forming polymers, propylene glycol as a plasticizer, and menthol as a permeation enhancer. The optimized formulation, CO-RUT (F1), exhibited favorable physicochemical characteristics, including rapid drying (56 ± 2 s), suitable viscosity (3.8 ± 0.076 cPs), and uniform drug content (95.3% ± 2%). <i>In vitro</i> release demonstrated sustained delivery over 8 h (86.7% ± 1.6%), following Korsmeyer-Peppas kinetics indicative of anomalous diffusion. <i>Ex vivo</i> permeation achieved 97.8% cumulative permeation, attributed to the synergistic effects of menthol and propylene glycol. Most critically, <i>in vivo</i> wound healing studies in rats showed complete wound closure by day 16, significantly outperforming marketed formulations and controls. Histopathological examination confirmed superior epithelialization, collagen deposition, and angiogenesis. The CO-RUT (F1) formulation which integrates QbD principles with robust experimental design demonstrates strong translational potential as a novel wound-healing platform and provides a methodological framework for developing next-generation film-forming sprays.</p>","PeriodicalId":20004,"journal":{"name":"Pharmaceutical Development and Technology","volume":" ","pages":"794-819"},"PeriodicalIF":2.9000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Development and Technology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10837450.2026.2682783","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Wound healing remains a major clinical challenge, necessitating advanced topical systems that accelerate repair while minimizing complications. Rutin, a flavonoid with potent antioxidant, anti-inflammatory and angiogenic properties, suffers from poor solubility and instability, limiting therapeutic application. To overcome these drawbacks, a rutin-loaded film-forming spray (FFS) was developed using a Quality by Design (QbD) framework and optimized via a Box-Behnken design. Eudragit® RLPO and Eudragit® E100 were employed as film-forming polymers, propylene glycol as a plasticizer, and menthol as a permeation enhancer. The optimized formulation, CO-RUT (F1), exhibited favorable physicochemical characteristics, including rapid drying (56 ± 2 s), suitable viscosity (3.8 ± 0.076 cPs), and uniform drug content (95.3% ± 2%). In vitro release demonstrated sustained delivery over 8 h (86.7% ± 1.6%), following Korsmeyer-Peppas kinetics indicative of anomalous diffusion. Ex vivo permeation achieved 97.8% cumulative permeation, attributed to the synergistic effects of menthol and propylene glycol. Most critically, in vivo wound healing studies in rats showed complete wound closure by day 16, significantly outperforming marketed formulations and controls. Histopathological examination confirmed superior epithelialization, collagen deposition, and angiogenesis. The CO-RUT (F1) formulation which integrates QbD principles with robust experimental design demonstrates strong translational potential as a novel wound-healing platform and provides a methodological framework for developing next-generation film-forming sprays.

“芦丁负载成膜喷雾加速伤口修复:qbd引导的翻译方法”。
伤口愈合仍然是一个主要的临床挑战,需要先进的局部系统来加速修复,同时最大限度地减少并发症。芦丁是一种黄酮类化合物,具有有效的抗氧化、抗炎和血管生成特性,但其溶解度和不稳定性差,限制了治疗应用。为了克服这些缺点,使用质量设计(QbD)框架开发了负载rutin的成膜喷雾(FFS),并通过Box-Behnken设计进行了优化。Eudragit®RLPO和Eudragit®E100被用作成膜聚合物,丙二醇作为增塑剂,薄荷醇作为渗透增强剂。优化后的CO-RUT (F1)具有快速干燥(56±2 s)、适宜的粘度(3.8±0.076 cPs)、均匀的含药量(95.3±2%)等理化特性。体外释放显示持续释放超过8小时(86.7±1.6%),遵循Korsmeyer-Peppas动力学表明异常扩散。由于薄荷醇和丙二醇的协同作用,体外渗透达到97.8%的累积渗透。最关键的是,在大鼠体内进行的伤口愈合研究显示,伤口在第16天完全愈合,明显优于市场上销售的配方和对照组。组织病理学检查证实有明显的上皮化、胶原沉积和血管生成。本研究建立了一种稳定的、符合患者要求的FFS,将QbD原理与稳健的实验设计相结合,实现了增强的局部递送和治疗效果。CO-RUT (F1)配方作为一种新型伤口愈合平台显示出强大的转化潜力,并为开发下一代成膜喷雾剂提供了方法框架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.90
自引率
2.90%
发文量
82
审稿时长
1 months
期刊介绍: Pharmaceutical Development & Technology publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems, emphasizing practical solutions and applications to theoretical and research-based problems. The journal aims to publish significant, innovative and original research to advance the frontiers of pharmaceutical development and technology. Through original articles, reviews (where prior discussion with the EIC is encouraged), short reports, book reviews and technical notes, Pharmaceutical Development & Technology covers aspects such as: -Preformulation and pharmaceutical formulation studies -Pharmaceutical materials selection and characterization -Pharmaceutical process development, engineering, scale-up and industrialisation, and process validation -QbD in the form a risk assessment and DoE driven approaches -Design of dosage forms and drug delivery systems -Emerging pharmaceutical formulation and drug delivery technologies with a focus on personalised therapies -Drug delivery systems research and quality improvement -Pharmaceutical regulatory affairs This journal will not consider for publication manuscripts focusing purely on clinical evaluations, botanicals, or animal models.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书